Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2963)
All Articles published online
|
Nov 27, 2011 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pellicelli AM, Marignani M, Zoli V, Romano M, Morrone A, Nosotti L, Barbaro G, Picardi A, Gentilucci UV, Remotti D, D'Ambrosio C, Furlan C, Mecenate F, Mazzoni E, Majolino I, Villani R, Andreoli A, Barbarini G. Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma. World J Hepatol 2011; 3(11): 278-284 [PMID: 22125661 DOI: 10.4254/wjh.v3.i11.278] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v3/i11/278.htm |
| Number | Citing Articles |
| 1 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_91-1
|
| 2 |
Adriano M. Pellicelli, Cecilia D’Ambrosio, Maria L. Dessanti, Roberto Villani, Lucia Fondacaro, Lucia Miglioresi, Lucia R. Grillo, Arnaldo Andreoli. Cholestatic hepatitis C after chemotherapy containing rituximab in diffuse large B cell lymphoma. Annals of Hepatology 2015; 14(5): 756 doi: 10.1016/S1665-2681(19)30773-2
|
| 3 |
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
|
| 4 |
Carlo Visco, Silvia Finotto. Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment. World Journal of Gastroenterology 2014; 20(32): 11054-11061 doi: 10.3748/wjg.v20.i32.11054
|
| 5 |
Semra Paydas. Hepatitis C virus and lymphoma. Critical Reviews in Oncology/Hematology 2015; 93(3): 246 doi: 10.1016/j.critrevonc.2014.10.008
|
| 6 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 1671 doi: 10.1007/978-3-319-26956-6_94
|
| 7 |
Gabriele Pozzato, Cesare Mazzaro, Luigino Dal Maso, Endri Mauro, Francesca Zorat, Giulia Moratelli, Pietro Bulian, Diego Serraino, Valter Gattei. Hepatitis C virus and non-Hodgkin’s lymphomas: Meta-analysis of epidemiology data and therapy options. World Journal of Hepatology 2016; 8(2): 107-116 doi: 10.4254/wjh.v8.i2.107
|
| 8 |
A. Schiavinato, A. Zanetto, G. Pantano, F. Tosato, M. Nabergoj, P. Fogar, E. Piva, M. Gambato, E. Franceschet, A. Floreani, F. Farinati, P. Burra, F. P. Russo, M. Plebani. Polyclonal and monoclonal B lymphocytes response in HCV‐infected patients treated with direct‐acting antiviral agents. Journal of Viral Hepatitis 2017; 24(12): 1168 doi: 10.1111/jvh.12746
|
| 9 |
Gian Paolo Caviglia, Claudio Sciacca, Maria Lorena Abate, Antonella Olivero, Chiara Rosso, Giovanni Antonio Touscoz, Alessia Ciancio, Mario Rizzetto, Antonina Smedile. Chronic hepatitis C virus infection and lymphoproliferative disorders: Mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B‐cell non‐Hodgkin lymphoma. Journal of Gastroenterology and Hepatology 2015; 30(4): 742 doi: 10.1111/jgh.12837
|
| 10 |
Anna Linda Zignego, Laura Gragnani, Alessia Piluso, Marco Sebastiani, Dilia Giuggioli, Poupak Fallahi, Alessandro Antonelli, Clodoveo Ferri. Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Review of Clinical Immunology 2015; 11(1): 15 doi: 10.1586/1744666X.2015.997214
|
| 11 |
Ling Zhang, Roger Klein. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics. 2012; : 157 doi: 10.1007/978-94-007-5028-9_9
|
| 12 |
Michele Merli, Sara Rattotti, Manuel Gotti, Luca Arcaini. Antiviral therapies for managing viral hepatitis in lymphoma patients. Expert Opinion on Pharmacotherapy 2017; 18(4): 363 doi: 10.1080/14656566.2017.1288718
|
| 13 |
Michele Merli, Giuseppe Carli, Luca Arcaini, Carlo Visco. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma. World Journal of Gastroenterology 2016; 22(38): 8447-8458 doi: 10.3748/wjg.v22.i38.8447
|
| 14 |
Alfredo Marzano, Emanuele Angelucci, Marco Astegiano, Chiara Baratelli, Luigi Biancone, Paolo Bironzo, Giuseppina Brancaccio, Maurizia Rossana Brunetto, Raffaele Bruno, Patrizia Burra, Maria Giuseppina Cabras, Paolo Caraceni, Claudia Chialà, Maria Grazia Clemente, Agostino Colli, Bruno Daniele, Elisabetta De Gasperi, Vito Di Marco, Maria Chiara Ditto, Stefano Fagiuoli, Clodoveo Ferri, Giovanni Battista Gaeta, Paolo Antonio Grossi, Barbara Imperatrice, Pietro Lampertico, Fabio Salvatore Macaluso, Salvatore Madonia, Massimo Marignani, Chiara Mazzarelli, Alberto Mella, Gabriele Missale, Simone Parisi, Luisa Pasulo, Massimo Puoti, Maria Rendina, Davide Ribaldone, Giuseppe Rossi, Pierluigi Toniutto, Alessandra Tucci, Pietro Vajro, Mauro Viganò, Riccardo Volpes, Anna Linda Zignego. AISF position paper on HCV in immunocompromised patients. Digestive and Liver Disease 2019; 51(1): 10 doi: 10.1016/j.dld.2018.09.022
|
| 15 |
Elisabetta Degasperi, Alessio Aghemo, Massimo Colombo. Treatment of Extrahepatic Manifestations of Hepatitis C Virus. Clinics in Liver Disease 2017; 21(3): 631 doi: 10.1016/j.cld.2017.03.015
|
| 16 |
Fabio Forghieri, Mario Luppi, Patrizia Barozzi, Rossana Maffei, Leonardo Potenza, Franco Narni, Roberto Marasca. Pathogenetic Mechanisms of Hepatitis C Virus-Induced B-Cell Lymphomagenesis. Clinical and Developmental Immunology 2012; 2012: 1 doi: 10.1155/2012/807351
|
| 17 |
Barbara Vannata, Luca Arcaini, Emanuele Zucca. Hepatitis C virus-associated B-cell non-Hodgkin’s lymphomas: what do we know?. Therapeutic Advances in Hematology 2016; 7(2): 94 doi: 10.1177/2040620715623924
|
| 18 |
Ivan Dlouhy, Miguel Á. Torrente, Sabela Lens, Jordina Rovira, Laura Magnano, Eva Giné, Julio Delgado, Olga Balagué, Antonio Martínez, Elías Campo, Xavier Forns, José M. Sánchez-Tapias, Armando López-Guillermo. Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Annals of Hematology 2017; 96(3): 405 doi: 10.1007/s00277-016-2903-8
|
| 19 |
Marcella Visentini, Massimo Fiorilli, Milvia Casato. From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?. Expert Review of Hematology 2017; 10(8): 719 doi: 10.1080/17474086.2017.1349607
|
| 20 |
Michiel van den Brand, Blanca Scheijen, Corine J. Hess, J. Han JM van Krieken, Patricia J.T.A. Groenen. Pathways towards indolent B-cell lymphoma — Etiology and therapeutic strategies. Blood Reviews 2017; 31(6): 426 doi: 10.1016/j.blre.2017.08.002
|
| 21 |
Giovanni Galati, Lorenzo Rampa, Umberto Vespasiani-Gentilucci, Mirella Marino, Francesco Pisani, Carlo Cota, Alessandro Guidi, Antonio Picardi. Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy. World Journal of Hepatology 2016; 8(29): 1244-1250 doi: 10.4254/wjh.v8.i29.1244
|
| 22 |
Retrospective Study of Hepatitis C Virus Genotypes and its Association with Lymphoma. Journal of Cancer Research Updates 2014; 3(3) doi: 10.6000/1929-2279.2014.03.03.2
|
| 23 |
HIROKI NISHIKAWA, MITSURU TSUDO, YUKIO OSAKI. Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experience. Oncology Reports 2012; 28(3): 835 doi: 10.3892/or.2012.1883
|
| 24 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 1617 doi: 10.1007/978-3-319-26956-6_91
|
| 25 |
Barbara Vannata, Emanuele Zucca. Hepatitis C virus-associated B-cell non-Hodgkin lymphomas. Hematology 2014; 2014(1): 590 doi: 10.1182/asheducation-2014.1.590
|
| 26 |
Hussein Khaled, Fouad Abu-Taleb, Rasha Haggag. Hepatitis C virus and non-Hodgkin’s lymphomas: A minireview. Journal of Advanced Research 2017; 8(2): 131 doi: 10.1016/j.jare.2016.11.005
|
| 27 |
S.M. Criscione. May viral (antigen) load be the real crucial tool leading to anergy in a “micro-evolutionary” model of host/virus interaction?. Medical Hypotheses 2012; 79(6): 774 doi: 10.1016/j.mehy.2012.08.026
|
| 28 |
Mihály Sulyok, Mihály Makara, Eszter Újhelyi, István Vályi-Nagy. Non-Hodgkin Lymphoma and Hepatitis C: Where We are and What Next?. Pathology & Oncology Research 2015; 21(1): 1 doi: 10.1007/s12253-014-9845-z
|
| 29 |
Albert Ndzengue, Lewis R. Roberts. Viruses and Human Cancer. 2014; : 51 doi: 10.1007/978-1-4939-0870-7_4
|
| 30 |
J. Peveling‐Oberhag, L. Arcaini, K. Bankov, S. Zeuzem, E. Herrmann. The anti‐lymphoma activity of antiviral therapy in HCV‐associated B‐cell non‐Hodgkin lymphomas: a meta‐analysis. Journal of Viral Hepatitis 2016; 23(7): 536 doi: 10.1111/jvh.12518
|
| 31 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_94-1
|
| 32 |
Xiang Zhou, Katharina Lisenko, Nicola Lehners, Juliane Brandt, Martin Cremer, Mark Kriegsmann, Anthony Dick Ho, Mathias Witzens-Harig. HCV load as a possible prognostic factor in patients with HCV-related DLBCL. Annals of Hematology 2018; 97(2): 351 doi: 10.1007/s00277-017-3124-5
|
| 33 |
Jeff Hosry, Parag Mahale, Francesco Turturro, Roberto N. Miranda, Minas P. Economides, Bruno P. Granwehr, Harrys A. Torres. Antiviral therapy improves overall survival in hepatitis C virus‐infected patients who develop diffuse large B‐cell lymphoma. International Journal of Cancer 2016; 139(11): 2519 doi: 10.1002/ijc.30372
|
| 34 |
L. Couronné, E. Bachy, S. Roulland, B. Nadel, F. Davi, M. Armand, D. Canioni, J.M. Michot, C. Visco, L. Arcaini, C. Besson, O. Hermine. From hepatitis C virus infection to B-cell lymphoma. Annals of Oncology 2018; 29(1): 92 doi: 10.1093/annonc/mdx635
|
| 35 |
Mario Masarone, Marcello Persico. Hepatitis C virus infection and non‐hepatocellular malignancies in the DAA era: A systematic review and meta‐analysis. Liver International 2019; 39(7): 1292 doi: 10.1111/liv.14119
|
| 36 |
Jan Peveling-Oberhag, Luca Arcaini, Martin-Leo Hansmann, Stefan Zeuzem. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. Journal of Hepatology 2013; 59(1): 169 doi: 10.1016/j.jhep.2013.03.018
|
| 37 |
Vincenzo Occhipinti, Lucia Farina, Mauro Viganò, Marco Capecchi, Sara Labanca, Ilaria Fanetti, Paolo Corradini, Mariagrazia Rumi. Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma. Digestive and Liver Disease 2019; 51(5): 719 doi: 10.1016/j.dld.2018.10.019
|